H275Y Mutant Pandemic (H1N1) 2009 Virus in Immunocompromised Patients

H275Y Mutant Pandemic (H1N1) 2009 Virus in Immunocompromised Patients

Most oseltamivir-resistant pandemic (H1N1) 2009 viruses have been isolated from immunocompromised patients. To describe the clinical features, treatment, outcomes, and virologic data associated with infection from pandemic (H1N1) 2009 virus with H275Y mutation in immunocompromised patients, we retro...

Full description

Bibliographic Details
Main Authors: Christian Renaud, Alexandre A. Boudreault, Jane Kuypers, Kathryn H. Lofy, Lawrence Corey, Michael J. Boeckh, Janet A. Englund
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2011-04-01
Series:Emerging Infectious Diseases
Subjects:
Influenza
oseltamivir
immunocompromised host
diagnosis
treatment outcome
antiviral drug resistance
Online Access:https://wwwnc.cdc.gov/eid/article/17/4/10-1429_article

Similar Items

Similar Items